Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Drug Analysis Service - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 167901
Later capture
Drug Analysis Service - Canada.ca
Jan 2, 2026
hc-20260101
ID 428782
updated2 sections changed
2 sections changed0 added0 removed+3 / -2 linesChange ratio: 1%
--- +++ @@ -84,6 +84,8 @@ Note: The hyperlink grants access to a wide array of search options for retrieving data related to the analysis of illicit drugs since 2020. Users can explore data on various aspects such as: annual, quarterly, provincial, and specific substances. Drug notification map Drug Classification+In Focus: The Emergence of Opioids in Canada+At-a-glance: New psychoactive substances in Canada - 2024 At-a-glance: New psychoactive substances in Canada - 2023 At-a-glance: New psychoactive substances in Canada - 2022 Emergence of Desalkylgidazepam, a novel benzodiazepine in Canada@@ -207,5 +209,4 @@ Drug Analysis Service: Trends 2012-2020 Drug analysis Service: Summary report of samples analyzed in 2020 Page details-Date modified:-2025-02-21+2025-09-29